BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 28416184)

  • 1. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.
    Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A
    Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
    Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
    Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity.
    Yuan B; Liu J; Shi A; Cao J; Yu Y; Zhu Y; Zhang C; Qiu Y; Luo H; Shi J; Cao X; Xu P; Shen L; Liang T; Zhao B; Feng XH
    EMBO J; 2023 Feb; 42(4):e111549. PubMed ID: 36598329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.
    von Eyss B; Jaenicke LA; Kortlever RM; Royla N; Wiese KE; Letschert S; McDuffus LA; Sauer M; Rosenwald A; Evan GI; Kempa S; Eilers M
    Cancer Cell; 2015 Dec; 28(6):743-757. PubMed ID: 26678338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
    Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
    J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
    Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
    J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.
    Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS
    Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin signalling regulates YAP and TAZ to control skin homeostasis.
    Elbediwy A; Vincent-Mistiaen ZI; Spencer-Dene B; Stone RK; Boeing S; Wculek SK; Cordero J; Tan EH; Ridgway R; Brunton VG; Sahai E; Gerhardt H; Behrens A; Malanchi I; Sansom OJ; Thompson BJ
    Development; 2016 May; 143(10):1674-87. PubMed ID: 26989177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.
    Raghunathan VK; Dreier B; Morgan JT; Tuyen BC; Rose BW; Reilly CM; Russell P; Murphy CJ
    PLoS One; 2014; 9(10):e109811. PubMed ID: 25290150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
    Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
    Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
    J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells.
    Fu J; Liu W; Liu S; Zhao R; Hayashi T; Zhao H; Xiang Y; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Cell Signal; 2024 Jul; 119():111186. PubMed ID: 38643945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.
    Yan L; Cai Q; Xu Y
    Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth.
    Gargini R; Escoll M; García E; García-Escudero R; Wandosell F; Antón IM
    Cell Rep; 2016 Nov; 17(8):1962-1977. PubMed ID: 27851961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.